UMIN ID: UMIN000014861
Registered date:15/08/2014
The utility and safety of intraperitoneal administration by microbubble agents for cirrhosis with refractory ascites
Basic Information
| Recruitment status | Open public recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Cirrhosis with refractory ascites |
| Date of first enrollment | 2014/08/15 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Contrast-enhanced ultrasound |
Outcome(s)
| Primary Outcome | The safety of intraperitoneal administration by microbubble contrast agents |
|---|---|
| Secondary Outcome | Transit time to circulation of blood from the time of intraperitoneal administration by microbubble contrast agents |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | Cirrotic patients with refractory ascites |
| Exclude criteria | ･Child-Pugh grade C ･Egg allergy ･Spontaneous bacterial peritonitis |
Related Information
| Primary Sponsor | Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tadashi Sekimoto |
| Address | 1-8-1, Inohana, Chuou-ku, Chiba, Japan Japan |
| Telephone | 043-226-2083 |
| tad_sekimoto@chiba-u.jp | |
| Affiliation | Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology |
| scientific contact | |
| Name | Hitoshi Maruyama |
| Address | 1-8-1, Inohana, Chuou-ku, Chiba, Japan Japan |
| Telephone | 043-226-2083 |
| maru-cib@umin.ac.jp | |
| Affiliation | Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology |